Immunotherapies inducing immunogenic cell death in cancer: insight of the innate immune system
KM Calvillo-Rodríguez, HY Lorenzo-Anota… - Frontiers in …, 2023 - frontiersin.org
Cancer immunotherapies include monoclonal antibodies, cytokines, oncolytic viruses,
cellular therapies, and other biological and synthetic immunomodulators. These are …
cellular therapies, and other biological and synthetic immunomodulators. These are …
Loss of GABARAP mediates resistance to immunogenic chemotherapy in multiple myeloma
Immunogenic cell death (ICD) is a form of cell death by which cancer treatments can induce
a clinically relevant antitumor immune response in a broad range of cancers. In multiple …
a clinically relevant antitumor immune response in a broad range of cancers. In multiple …
DAMPening Tumor Immune Escape: The Role of Endoplasmic Reticulum Chaperones in Immunogenic Chemotherapy
Significance: Preclinical and clinical research in the past two decades has redefined the
mechanism of action of some chemotherapeutics that are able to activate the immune …
mechanism of action of some chemotherapeutics that are able to activate the immune …
Immunogenic cell stress and death sensitize tumors to immunotherapy
The efficacy of chemotherapy with cytotoxicants and that of targeted therapies with more
sophisticated agents is limited due to the plasticity of malignant cells, which leads to the …
sophisticated agents is limited due to the plasticity of malignant cells, which leads to the …
Cytotoxic Effects of the Combination of Pam3CSK4 with Carfilzomib, Ixazomib, and Venetoclax in Human Multiple Myeloma Cells
K Avci, MÖ Erdoğan, SH Yildiz, F Yavaşoğlu - Molecular Biology, 2024 - Springer
Proteasome inhibitors (PIs) are effective in the treatment of multiple myeloma (MM), which is
a plasma cell malignancy. Different options for treating MM are a subject of research …
a plasma cell malignancy. Different options for treating MM are a subject of research …